[ad_1]
Schaffhausen (awp) – BB Biotech anticipates a loss of about CHF 70 million in the first half of fiscal 2018. During the same period of the previous year, the company's 39; investment specialized in biotechnology had made a profit of 478.4 million euros.
As an investment, the result reflects the stock market performance of the companies held in the portfolio. Press release The course of action in the meantime – measured in Swiss francs – in the same period rose by 8.4%.
The definitive figures will be published on July 20, 2018.
ra / cf
[ad_2]
Source link
